AksharChem India Q2 FY27 Profit Soars to ₹1,332 Lakhs, Revenue Jumps 79.7%
AksharChem India's unaudited standalone results for Q2 FY27 show Total Income from Operations at ₹16,048.24 lakhs, up from ₹8,930.24 lakhs YoY. Net Profit after tax surged to ₹1,332.16 lakhs from a loss of ₹136.90 lakhs. EPS for the quarter was ₹16.58 compared to ₹(1.70) YoY.
The substantial improvement in financial performance, particularly the shift from a net loss to a significant net profit and the substantial revenue growth, is expected to have a high positive impact on investor sentiment and the company's stock.
The company has reported a significant increase in revenue and a strong turnaround in net profit for the quarter and half-year ended September 30, 2026, compared to the previous year.
AksharChem India Limited has announced its unaudited standalone financial results for the quarter and half-year ended September 30, 2026. The company reported a significant increase in its financial performance compared to the previous year.
For the quarter ended September 30, 2026, AksharChem India's Total Income from Operations stood at ₹16,048.24 lakhs, a substantial rise from ₹8,930.24 lakhs in the same period last year. Consequently, the Net Profit for the period after tax surged to ₹1,332.16 lakhs, a marked improvement from a loss of ₹136.90 lakhs in the corresponding quarter of the previous year. The Total Comprehensive Income also saw a positive shift, reaching ₹1,298.16 lakhs from a loss of ₹166.60 lakhs.
During the half-year ended September 30, 2026, the Total Income from Operations was ₹30,135.27 lakhs. The Net Profit after tax for the half-year was ₹2,853.40 lakhs, a significant turnaround from ₹136.90 lakhs (loss) in the same period last year. Basic and Diluted Earnings Per Share (EPS) for the quarter were ₹16.58, compared to ₹(1.70) in the prior year quarter. For the half-year, EPS stood at ₹35.52, up from ₹(1.70) in the previous year.
The company has published these results in the Business Standard (English) and Jay Hind (Gujarati) newspapers on October 20, 2026, in compliance with Regulation 47 of the SEBI Listing Regulations. The full financial results are available on the company's website and the stock exchange websites.
What to do with a filing like this
AksharChem India Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by AksharChem India Limited. Read the original for the full detail.